Company: WHWK
Filing Date: 2025-01-21
Form Type: PREM14A
Source: 0001193125-25-009599
Chunk: 854

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-21
Form: PREM14A
Chunk 854
---
of and supersede all prior and contemporaneous agreements, representations and/or understandings, including the Prior CDA. No terms or provisions of this Agreement shall be varied or
modified by any prior or subsequent statement, conduct or act of either of the Parties, except that the Parties may amend this Agreement by written instruments specifically referring to and executed in the same manner as this Agreement.

G-30

16.7 Notices. Unless otherwise agreed by the Parties or specified in this Agreement, all communications between the Parties relating to, and all written documentation to be prepared and provided under, this Agreement shall be in the English language. Any notice between the Parties required or permitted under this Agreement shall be in writing in the English language, and (a) delivered personally, (b) sent by air mail or express courier service providing evidence of receipt, postage pre-paid where applicable, or (c) by email and acknowledged by return email, to the following addresses of the Parties (or such other address for a Party as may be specified by like notice):

| To WuXi Biologics:                           
 WuXi Biologics (Shanghai FX) CO., Ltd. [***] 
 Attention: [***] Email: [***]                |     | To Aadi:                                            
 Aadi Bioscience, Inc. [***]                         
 Attention: [***] Email: [***]                       |
| With a copy to:                              
 WuXi Biologics (Shanghai) CO., Ltd. [***]    
 Attention: [***] Email: [***]                |     | With a copy to (which shall not constitute notice): 
 Wilson Sonsini Goodrich & Rosati [***]              
 Attention: [***]  Email: [***]                      |

Any notice required or permitted to be given concerning this Agreement shall be effective upon receipt by the Party to whom it is addressed. 16.8 Assignment. Neither Party may assign or transfer (whether by operation of Applicable Law or otherwise) this Agreement or any rights or obligations hereunder without the prior written consent of the other, except that a Party may assign or transfer this Agreement, and all of its rights and obligations hereunder, without the other Party’s consent, to (a) an Affiliate or (b) to a Third Party that is a successor to substantially all of the business to which this Agreement relates, whether in a merger, sale of stock, sale of assets, reorganization or other transaction. Notwithstanding the foregoing, [***]. Notwithstanding the foregoing, WuXi